The other main results from our study were: 1) a significant increase in CSF NfL in IDD and MCI-AD/AD-dem patients as compared with PD patients and to the control group; 2) no significant differences in CSF NfL in PD patients as compared with controls; 3) a significant association between CSF NfL and several clinical and radiological disease severity measures in IDD patients; and 4) no significant correlations between CSF NfL and clinical variables in MCI-AD/AD-dem and PD patients. The gene discussed is NEFL; the disease is Alzheimer disease.